IGM Biosciences, Inc.

NasdaqGS:IGMS Stock Report

Market Cap: US$528.6m

IGM Biosciences Management

Management criteria checks 2/4

IGM Biosciences' CEO is Mary Harler, appointed in Oct 2024, has a tenure of less than a year. directly owns 0.59% of the company’s shares, worth $3.10M. The average tenure of the management team and the board of directors is 3 years and 6 years respectively.

Key information

Mary Harler

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.6%
Management average tenure3yrs
Board average tenure6yrs

Recent management updates

Recent updates

We're Not Very Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate

Oct 08
We're Not Very Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate

IGM Biosciences: Waiting For Godot

Sep 18

IGM Biosciences: Unlikely To Move The Needle Again In 2024

May 12

Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Invest In Growth?

Apr 28
Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Invest In Growth?

IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points

Feb 12

We Think IGM Biosciences (NASDAQ:IGMS) Needs To Drive Business Growth Carefully

Nov 20
We Think IGM Biosciences (NASDAQ:IGMS) Needs To Drive Business Growth Carefully

We're Not Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn

May 10
We're Not Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn

Here's Why We're Not At All Concerned With IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

Jan 05
Here's Why We're Not At All Concerned With IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

IGM Biosciences (NASDAQ:IGMS) Is In A Strong Position To Grow Its Business

Sep 23
IGM Biosciences (NASDAQ:IGMS) Is In A Strong Position To Grow Its Business

IGM Biosciences started at BofA Securities with a buy on IgM antibody candidates

Aug 29

IGM Biosciences GAAP EPS of -$1.33 misses by $0.93, revenue of $0.4M

Aug 08

We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate

Jun 09
We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate

IGM Biosciences: Interesting Science, Poor Trial Data

Feb 23

Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Deliver On Growth Plans?

Feb 17
Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

Sep 07
Here's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation

IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans

May 25
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans

CEO

Mary Harler (59 yo)

less than a year

Tenure

Ms. Mary Beth Harler, M.D. is the Chief Executive Officer of IGM Biosciences, Inc. since October 01, 2024 and serves as its Director. She had been Head of Research & Autoimmunity at IGM Biosciences, Inc. s...


Leadership Team

NamePositionTenureCompensationOwnership
Mary Harler
CEO & Directorless than a yearno data0.59%
$ 3.1m
Misbah Tahir
Chief Financial Officer5.8yrsUS$1.08m0.035%
$ 186.3k
TS Harigopal
Senior Vice President of Group Operations1.8yrsno datano data
Steven Weber
Senior VP2.7yrsno data0.0043%
$ 22.9k
Paul Graffagnino
Senior Vice President of Legal Affairs3.8yrsno datano data
Suzette Tauber
Chief Human Resources Officer5.4yrsno datano data
Angus Sinclair
Executive Vice President of Research3.3yrsno datano data
Lisa Decker
Chief Business Officer3.7yrsUS$4.92m0.030%
$ 160.1k
Marvin Peterson
Executive Vice President of Process Development & Manufacturing3.6yrsno datano data
Elizabeth Haanes
Senior Vice President of Intellectual Property2.6yrsno datano data
Elaine Sapinoso
Senior Vice President of Quality1.8yrsno datano data
Faraz Siddiqui
Senior Vice President of Manufacturing Operations1.3yrsno datano data

3.0yrs

Average Tenure

55yo

Average Age

Experienced Management: IGMS's management team is considered experienced (3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mary Harler
CEO & Directorno datano data0.59%
$ 3.1m
Felix Baker
Independent Director3.8yrsUS$168.55k0.0037%
$ 19.7k
M. Behrens
Independent Director5.8yrsUS$178.30k0.68%
$ 3.6m
Mark Davis
Member of Scientific Advisory Boardno datano datano data
Rafi Ahmed
Member of Scientific Advisory Boardno datano datano data
Michael Lee
Independent Director5.3yrsUS$166.09k0.016%
$ 82.9k
Jakob Topsoe
Independent Director6.3yrsUS$166.09k0.15%
$ 785.2k
Julie Hambleton
Independent Director6.3yrsUS$204.09k0.0034%
$ 17.8k
Christina Topsoe
Independent Director6.3yrsUS$175.84k0.099%
$ 522.6k
William Strohl
Independent Director6.3yrsUS$236.59k0%
$ 0
Elizabeth Thompson
Independent Director1.1yrsUS$167.54k0.0073%
$ 38.7k
Gordon J. Freeman
Member of Scientific Advisory Boardno datano datano data

6.0yrs

Average Tenure

55yo

Average Age

Experienced Board: IGMS's board of directors are considered experienced (6 years average tenure).